Generic Pipeline

Programs Under DevelopmentBranded Product EquivalentTherapeutic CategoryDevelopment Stage
ELI-300 OpioidUndisclosedPainEarly Development
ELI-301 OpioidUndisclosedPainEarly Development
Oxycodone Hydrochloride ER with ADT, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 60 mg and 80 mg TabletsOxyContin® ADTPainLate Stage Development
Oxycodone Hydrochloride and Acetaminophen, USP 5 mg/325 mg, 7.5 mg/325 mg, 10 mg/325 mg TabletsPercocet®PainPending FDA Approval
Hydrocodone Bitartrate and Acetaminophen, USP 5 mg/325 mg, 7.5 mg/325 mg and 10 mg/325 mg Tablets Norco®PainPending FDA Approval
Synthetic Narcotic AnalgesicUndisclosedPainPending FDA Approval
Undisclosed GenericUndisclosedUndisclosedPending FDA Approval